In a working paper, Roosevelt Senior Economist and Policy Counsel Lenore Palladino investigates whether stock buybacks occur more frequently, independent of other factors, when corporate insiders are selling their own personal shareholdings. In her empirical analysis of the relationship between insider sales and stock buybacks, Palladino finds that a 10 percent increase in insider sales

FOR IMMEDIATE RELEASE: June 19, 2019 CONTACT: Ariela Weinberger, aweinberger@rooseveltinstitute.org The High Cost of Shareholder Power in Big Pharma New Roosevelt brief illustrates the magnitude of Big Pharma spending on shareholders NEW YORK, NY – At a time when Americans pay record prices for medications, pharmaceutical companies generate record profits devoted largely to rewarding shareholders

Despite Big Pharma’s claim that high-cost medicines are the price society must pay for innovation, recent research provides ample evidence that overpriced medicines are not necessary for the industry to find cures or revolutionize. Rather, high-cost and low-quality medicines are the price patients pay for an industry that prioritizes profit-seeking over public health. Like all

Tomorrow at Walmart’s shareholders’ meeting in Bentonville, Arkansas, Walmart workers will call out America’s broken corporate governance system and propose that Walmart workers be included on its board of directors. Walmart associate Cat Davis will be joined by Senator Bernie Sanders (I-VT), who will speak on behalf of workers’ right to participate in corporate decision-making.

Economic inequality is on the rise. Corporate “shareholder primacy” means that the vast majority of today’s record corporate profits are used to increase the wealth of shareholders, through dividends and stock buybacks.[1] Meanwhile, real wages for non-executive workers have essentially remained stagnant for decades. Increasing worker bargaining power in the 21st century is necessary, and

The pharmaceutical industry isn’t working for most people in the US. Over 80 percent of Americans across the political spectrum believe that lowering drug costs should be a “top priority” for lawmakers and believe that prescription drug costs are “unreasonable.” This growing scrutiny presents an opportunity to question the ways that drug corporations run business, as

For nearly half of a century, America’s public corporations have been driven by a shareholder primacy approach to corporate governance, increasingly prioritizing shareholder payments over other, more productive uses of corporate resources. Over the same period, employee bargaining power has decreased and wages for nonexecutive workers have remained flat across sectors. In Ending Shareholder Primacy in Corporate Governance,

FOR IMMEDIATE RELEASE: February 14, 2019 CONTACT: Ariela Weinberger, aweinberger@rooseveltinstitute.org   Roosevelt Senior Economist Explores Corporate Prosperity and the Decline of Employee Bargaining Power Research finds that the rise of shareholder primacy has contributed to America’s high-profit, low-wage economy   NEW YORK, NY – Today, the Roosevelt Institute, a New York-based think tank that promotes

One justification made by proponents of stock buybacks is that the practice is an effective way for funds to flow from companies that do not “need” the cash out to shareholders, who will then invest it in companies that are issuing new shares to finance firm activity. Does this explanation show up in the data?1

Today, Senator Bernie Sanders (I-VT) and Congressman Ro Khanna (D-CA) introduced the STOP Walmart Act, which prohibits large companies from engaging in stock buybacks unless they make serious investments in their workers. While the act takes aim at Walmart, the country’s largest private employer, it highlights the theme of my work: that excessive giveaways to